Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair^® versus HandiHaler^® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial

References

• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2016 Available from: http://www.goldcopd.org/Accessed May 1, 2016
   Google Scholar
• QaseemAWiltTJWeinbergerSEAmerican College of PhysiciansAmerican College of Chest PhysiciansAmerican Thoracic Society; European Respiratory SocietyDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
   PubMed Web of Science ®Google Scholar
• JansonCMarksGBuistSThe impact of COPD on health status: findings from the BOLD studyEur Respir J20134261472148323722617
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLHartlSPozo-RodriguezFRobertsCMEuropean COPD Audit teamVariability of hospital resources for acute care of COPD patients: the European COPD auditEur Respir J201443375476223988775
   PubMed Web of Science ®Google Scholar
• World Health OrganizationCOPD predicted to be third leading cause of death in 2030 [webpage on the Internet]GenevaWorld Health Organization2008 Available from: http://www.who.int/respiratory/copd/World_Health_Statistics_2008/en/index.htmlAccessed December 25, 2015
   Google Scholar
• MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2007311e442
   Web of Science ®Google Scholar
• YohannesAMConnollyMJHananiaNATen years of tiotropium: clinical impact and patient perspectivesInt J Chron Obstruct Pulmon Dis2013811712523515335
   PubMed Web of Science ®Google Scholar
• Alvarado-GonzalezAArceITiotropium bromide in chronic obstructive pulmonary disease and bronchial asthmaJ Clin Med Res201571183183926491494
   PubMedGoogle Scholar
• TashkinDPCelliBSennSfor UPLIFT study investigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• HalpinDMDahlRHallmannCMuellerATashkinDTiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysisInt J Chron Obstruct Pulmon Dis20151023925925709423
   PubMed Web of Science ®Google Scholar
• VerhammeKMAfonsoARomioSStrickerBCBrusselleGGSturkenboomMCUse of tiotropium respimat soft mist Inhaler versus HandiHaler and mortality in patients with COPDEur Respir J201342360661523520322
   PubMed Web of Science ®Google Scholar
• BourbeauJBartlettSJPatient adherence in COPDThorax200863983183818728206
   PubMed Web of Science ®Google Scholar
• HalpernRBakerCLSuJOutcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary diseasePatient Prefer Adherence2011537538821845037
   PubMed Web of Science ®Google Scholar
• Koehorst-ter HuurneKMovigKvan der ValkPvan der PalenJBrusse-KeizerMDifferences in adherence to common inhaled medications in COPDCOPD201512664364825775100
   PubMedGoogle Scholar
• Boehringer IngelheimSpiriva 18 microgram inhalation powder, hard capsule. Summary of Product Characteristics (SPC), Electronic Medicines Compendium (EMC) Available from: http://www.medicines.org.uk/emc/medicine/10039/SPC/Spiriva+18+microgram+inhalation+powder%2c+hard+capsule/Accessed December 19, 2015
   Google Scholar
• Boehringer IngelheimSpiriva Respimat 2.5 microgram solution for inhalation. Summary of Product Characteristics (SPC), Electronic Medicines Compendium (EMC) Available from: http://www.medicines.org.uk/emc/medicine/20134/SPCAccessed December 19, 2015
   Google Scholar
• Boehringer IngelheimBoehringer Ingelheim submits application in Europe to extend the indication for the use of tiotropium Respimat^® to the treatment of asthma in adults aged 18 years and over [press release archive: asthma]Ingelheim, GermanyBoehringer Ingelheim20131113 Available from: http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2013/13_november_2013_tiotropium.htmlAccessed December 19, 2015
   Google Scholar
• GeorgeJKongDCMThomanRStewartKFactors associated with medication non-adherence in patients with COPDChest200512853198320416304262
   PubMed Web of Science ®Google Scholar
• HanadaSWadaSOhnoTSawaguchiHMurakiMTohdaYQuestionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switchInt J Chron Obstruct Pulmon Dis201510697725609941
   PubMed Web of Science ®Google Scholar
• RandCSPatient adherence with COPD therapyEur Respir Rev20051497101
   Google Scholar
• CazzolaMMateraMGNovel long-acting bronchodilators for COPD and asthmaBr J Pharmacol2008155329129918604231
   PubMed Web of Science ®Google Scholar
• BatemanEDImproving inhaler use in COPD and the role of patient preferenceEur Respir Rev2005148588
   Google Scholar
• ChapmanKRFogartyCMPeckittCDelivery characteristics and patients’ handling of two single-dose dry-powder inhalers used in COPDInt J Chron Obstruct Pulmon Dis2011635336321760722
   PubMed Web of Science ®Google Scholar
• HesselinkAEPenninxBWWijnhovenHAKriegsmanDMvan EijkJTDeterminants of an incorrect inhalation technique in patients with asthma or COPDScand J Prim Health Care200119425526011822651
   PubMed Web of Science ®Google Scholar
• VinckenWDekhuijzenPRBarnesPADMIT GroupThe ADMIT series – Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPDPrim Care Respir J2010191102019890594
   PubMedGoogle Scholar
• FromerLGoodwinEWalshJCustomizing inhaled therapy to meet the needs of COPD patientsPostgrad Med20101222839320203459
   PubMed Web of Science ®Google Scholar
• MäkeläMJBackerVHedegaardMLarssonKAdherence to inhaled therapies, health outcomes and costs in patients with asthma and COPDRespir Med2013107101481149023643487
   PubMed Web of Science ®Google Scholar
• GuptaSHow to ensure the correct inhaler device is selected for each patientClin Pharmacist20091322323
   Google Scholar
• DahlRBackerVOllgaardBGerkenFKestenSAssessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instructionRespir Med200397101126113314561020
   PubMed Web of Science ®Google Scholar
• RuchiTVishalSNeetuKVikramjeetSRecent trends in DPI technologyInt Res J Pharm2012312734
   Google Scholar
• NicolaiJLTorvinenSMilesRGreaneyMHHowardDJPlichAThe potential societal cost benefits of increasing patient satisfaction by using an inhaler with improved features compared to Spiriva® HandiHaler® for the management of chronic obstructive pulmonary disease (COPD) in the UKValue Health201518A500
   Web of Science ®Google Scholar
• Van Der PalenJEijsvogelMMKuipersBFSchipperMVermueNAComparison of the Diskus inhaler and the HandiHaler regarding preference and ease of useJ Aerosol Med2007201384417388751
   PubMedGoogle Scholar
• ChorãoPPereiraAMFonsecaJAInhaler devices in asthma and COPD-an assessment of inhaler technique and patient preferencesRespir Med2014108796897524873873
   PubMed Web of Science ®Google Scholar
• HananiaNASharmaGSharafkhanehACOPD in the elderly patientSemin Respir Crit Care Med201031559660620941660
   PubMed Web of Science ®Google Scholar
• TaffetGEDonohueJFAltmanPRConsiderations for managing chronic obstructive pulmonary disease in the elderlyClin Interv Aging20149233024376347
   PubMed Web of Science ®Google Scholar
• HodderRPriceDPatient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhalerInt J Chron Obstruct Pulmon Dis2009438139019888356
   PubMedGoogle Scholar
• Neutec Tiofix Discair Product information Available from: http://www.neutec.com.tr/pdf/solunum-sistemi-ilaclari/tiofix-18-mcg-Discair-inh-icin-Toz-Kub.pdfAccessed January 14, 2016
   Google Scholar
• Lopez-CamposJLCaleroCLopez-RamirezCAsensio-CruzMIMárquez-MartínEOrtega-RuizFPatient-reported outcomes and considerations in the management of COPD: focus on aclidiniumPatient Prefer Adher2015995104
   PubMed Web of Science ®Google Scholar
• BrashierBDhembarePJantikarATiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPDRespir Med2007101122464247117719763
   PubMed Web of Science ®Google Scholar
• ShavroSAEzhilarasuPAugustineJBechtelJJChristopherDJCorrelation of health-related quality of life with other disease severity indices in Indian chronic obstructive pulmonary disease patientsInt J Chron Obstruct Pulmon Dis2012729129622615528
   PubMed Web of Science ®Google Scholar
• VinckenWvan NoordJAGreefhorstAPImproved health outcomes in patients with COPD during 1 yr’s treatment with tiotropiumEur Respir J200219220921611871363
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLBustamanteVMunozXBarreiroEMoving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine – a critical viewChronic Obstr Pulm Dis2014115591602
   Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• FletcherCMThe clinical diagnosis of pulmonary emphysema; an experimental studyProc R Soc Med195245957758413003946
   PubMedGoogle Scholar
• SarinasPSRobinsonTEClarkARCanfieldJJrChitkaraRKFickRBJrInspiratory flow rate and dynamic lung function in cystic fibrosis and chronic obstructive lung diseasesChest199811449889929792566
   PubMed Web of Science ®Google Scholar
• CelliBZuWallackRWangSKestenSImprovement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumesChest200312451743174814605043
   PubMed Web of Science ®Google Scholar
• O’DonnellDEFlugeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPDEur Respir J200423683284015218994
   PubMed Web of Science ®Google Scholar
• CelliBartolome RChronic obstructive pulmonary disease phenotypes and their clinical relevanceProc Am Thorac Soc20063646146516921104
   PubMedGoogle Scholar
• ValenteSPasciutoGBernabeiRCorboGMDo we need different treatments for very elderly COPD patients?Respiration201080535736820733280
   PubMed Web of Science ®Google Scholar
• DecramerMMolenberghsGLiuDUPLIFT investigatorsPremature discontinuation during the UPLIFT studyRespir Med2011105101523153021530213
   PubMed Web of Science ®Google Scholar
• ChrystynHSmallMMilliganGHigginsVGilEGEstruchJImpact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPDRespir Med2014108235836524209768
   PubMed Web of Science ®Google Scholar
• IchinoseMFujimotoTFukuchiYTiotropium 5 microg via Respimat and 18 microg via HandiHaler; efficacy and safety in Japanese COPD patientsRespir Med2010104222823619969446
   PubMed Web of Science ®Google Scholar
• KeatingGMTiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary diseaseDrugs201272227330022217233
   PubMed Web of Science ®Google Scholar
• HohlfeldJMSharmaAvan NoordJAPharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary diseaseJ Clin Pharmacol201454440541424165906
   PubMed Web of Science ®Google Scholar